Cargando…
Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses
BACKGROUND: The primary objective of this study was to investigate if extended antibiotic treatment against bacterial vaginosis (BV) together with adjuvant lactobacilli treatment could cure BV and, furthermore, to investigate factors that could cause relapse. METHODS: In all, 63 consecutive women wi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176208/ https://www.ncbi.nlm.nih.gov/pubmed/21854593 http://dx.doi.org/10.1186/1471-2334-11-223 |
_version_ | 1782212195084402688 |
---|---|
author | Larsson, Per-Göran Brandsborg, Erik Forsum, Urban Pendharkar, Sonal Andersen, Kasper Krogh Nasic, Salmir Hammarström, Lennart Marcotte, Harold |
author_facet | Larsson, Per-Göran Brandsborg, Erik Forsum, Urban Pendharkar, Sonal Andersen, Kasper Krogh Nasic, Salmir Hammarström, Lennart Marcotte, Harold |
author_sort | Larsson, Per-Göran |
collection | PubMed |
description | BACKGROUND: The primary objective of this study was to investigate if extended antibiotic treatment against bacterial vaginosis (BV) together with adjuvant lactobacilli treatment could cure BV and, furthermore, to investigate factors that could cause relapse. METHODS: In all, 63 consecutive women with bacterial vaginosis diagnosed by Amsel criteria were offered a much more aggressive treatment of BV than used in normal clinical practice with repeated antibiotic treatment with clindamycin and metronidazole together with vaginal gelatine capsules containing different strains of lactobacilli both newly characterised and a commercial one (10(9 )freeze-dried bacteria per capsule). Oral clindamycin treatment was also given to the patient's sexual partner. RESULTS: The cure rate was 74.6% after 6 months. The patients were then followed as long as possible or until a relapse. The cure rate was 65.1% at 12 months and 55.6% after 24 months. There was no significant difference in cure rate depending on which Lactobacillus strains were given to the women or if the women were colonised by lactobacilli. The most striking factor was a new sex partner during the follow up period where the Odds Ratio of having a relapse was 9.3 (2.8-31.2) if the patients had a new sex partner during the observation period. CONCLUSIONS: The study shows that aggressive treatment of the patient with antibiotics combined with specific Lactobacillus strain administration and partner treatment can provide long lasting cure. A striking result of our study is that change of partner is strongly associated with relapse of BV. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01245322 |
format | Online Article Text |
id | pubmed-3176208 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31762082011-09-20 Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses Larsson, Per-Göran Brandsborg, Erik Forsum, Urban Pendharkar, Sonal Andersen, Kasper Krogh Nasic, Salmir Hammarström, Lennart Marcotte, Harold BMC Infect Dis Research Article BACKGROUND: The primary objective of this study was to investigate if extended antibiotic treatment against bacterial vaginosis (BV) together with adjuvant lactobacilli treatment could cure BV and, furthermore, to investigate factors that could cause relapse. METHODS: In all, 63 consecutive women with bacterial vaginosis diagnosed by Amsel criteria were offered a much more aggressive treatment of BV than used in normal clinical practice with repeated antibiotic treatment with clindamycin and metronidazole together with vaginal gelatine capsules containing different strains of lactobacilli both newly characterised and a commercial one (10(9 )freeze-dried bacteria per capsule). Oral clindamycin treatment was also given to the patient's sexual partner. RESULTS: The cure rate was 74.6% after 6 months. The patients were then followed as long as possible or until a relapse. The cure rate was 65.1% at 12 months and 55.6% after 24 months. There was no significant difference in cure rate depending on which Lactobacillus strains were given to the women or if the women were colonised by lactobacilli. The most striking factor was a new sex partner during the follow up period where the Odds Ratio of having a relapse was 9.3 (2.8-31.2) if the patients had a new sex partner during the observation period. CONCLUSIONS: The study shows that aggressive treatment of the patient with antibiotics combined with specific Lactobacillus strain administration and partner treatment can provide long lasting cure. A striking result of our study is that change of partner is strongly associated with relapse of BV. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01245322 BioMed Central 2011-08-19 /pmc/articles/PMC3176208/ /pubmed/21854593 http://dx.doi.org/10.1186/1471-2334-11-223 Text en Copyright ©2011 Larsson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Larsson, Per-Göran Brandsborg, Erik Forsum, Urban Pendharkar, Sonal Andersen, Kasper Krogh Nasic, Salmir Hammarström, Lennart Marcotte, Harold Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses |
title | Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses |
title_full | Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses |
title_fullStr | Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses |
title_full_unstemmed | Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses |
title_short | Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses |
title_sort | extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176208/ https://www.ncbi.nlm.nih.gov/pubmed/21854593 http://dx.doi.org/10.1186/1471-2334-11-223 |
work_keys_str_mv | AT larssonpergoran extendedantimicrobialtreatmentofbacterialvaginosiscombinedwithhumanlactobacillitofindthebesttreatmentandminimizetheriskofrelapses AT brandsborgerik extendedantimicrobialtreatmentofbacterialvaginosiscombinedwithhumanlactobacillitofindthebesttreatmentandminimizetheriskofrelapses AT forsumurban extendedantimicrobialtreatmentofbacterialvaginosiscombinedwithhumanlactobacillitofindthebesttreatmentandminimizetheriskofrelapses AT pendharkarsonal extendedantimicrobialtreatmentofbacterialvaginosiscombinedwithhumanlactobacillitofindthebesttreatmentandminimizetheriskofrelapses AT andersenkasperkrogh extendedantimicrobialtreatmentofbacterialvaginosiscombinedwithhumanlactobacillitofindthebesttreatmentandminimizetheriskofrelapses AT nasicsalmir extendedantimicrobialtreatmentofbacterialvaginosiscombinedwithhumanlactobacillitofindthebesttreatmentandminimizetheriskofrelapses AT hammarstromlennart extendedantimicrobialtreatmentofbacterialvaginosiscombinedwithhumanlactobacillitofindthebesttreatmentandminimizetheriskofrelapses AT marcotteharold extendedantimicrobialtreatmentofbacterialvaginosiscombinedwithhumanlactobacillitofindthebesttreatmentandminimizetheriskofrelapses |